OakChart

Senseonics Holdings Inc

SENSHealthcare·Medical Devices·USA·Small·NASD·Nov 11 • 12:01 PM ET

10.48+0.45 (4.49%)
2026-11-11 18:01 CET
Market cap
530.33 USD m
Revenue, TTM
60.01 USD m
Net income, TTM
-122.54 USD m
Free cash flow, TTM
-115.31 USD m
EPS diluted, TTM
-2.34
P/E
-
Compare

Price

SENS against its 20, 50 and 200-day averages
2050200beatmiss
5.007.5010.0012.502.8M5.7MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26SENSclose 10.4820-day 8.6650-day 9.16200-day 7.2810.4852w high52w low

25.0% under the 52-week high of 13.98 on 10 Nov 2026. 52-week low 4.79 on 5 May 2026. Last 15 sessions, 92.8% high to low

Profile

SENS
52-week range, 62% of the way up
4.7913.98

Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. Its primary product is the brand Eversense CGM (continuous glucose monitoring) including sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

IndexRUT
Employees130
IPODec 22, 2015
Beta1.02
ATR, 14d0.94
Rel volume1.85
Short float10.18%
Insider own11.93%
Inst own39.93%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap574.10M
Enterprise Value510.00M
Income-122.54M
Sales60.01M
Book/sh1.42
Cash/sh2.31
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees130
IPODec 22, 2015

Ratios

P/E-
Forward P/E-
PEG-
P/S9.57
P/B7.40
P/C4.53
P/FCF-
EV/EBITDA-
EV/Sales8.50
Quick Ratio5.60
Current Ratio5.92
Debt/Eq0.81
LT Debt/Eq0.76
Option/ShortYes / Yes

Earnings

EPS (ttm)-2.34
EPS next Y-1.84
EPS next Q-0.42
EPS this Y-33.41%
EPS next Y17.09%
EPS next 5Y4.31%
EPS past 3/5Y8.64% 35.96%
Sales past 3/5Y29.09% 48.10%
EPS Y/Y TTM-37.15%
Sales Y/Y TTM104.83%
EPS Q/Q-14.43%
Sales Q/Q141.64%
EarningsNov 09 AMC
EPS/Sales Surpr.3.14% 19.41%

Ownership

Insider Own11.93%
Insider Trans0.58%
Inst Own39.93%
Inst Trans19.91%
ROA-81.04%
ROE-157.32%
ROIC-89.64%
Gross Margin58.72%
Oper. Margin-200.99%
Profit Margin-204.19%
SMA2020.97%
SMA5014.46%
SMA20043.98%
Trades-

Technical

Shs Outstand54.78M
Shs Float46.57M
Short Float10.18%
Short Ratio6.26
Short Interest4.74M
52W High13.98 -25.03%
52W Low4.79 118.79%
Volatility17.28% 9.67%
ATR (14)0.94
RSI (14)62.69
Beta1.02
Rel Volume1.85
Avg Volume756.91K
Volume586,480

Performance

Perf Week16.19%
Perf Month17.49%
Perf Quarter35.58%
Perf Half Y90.55%
Perf YTD89.86%
Perf Year60.98%
Perf 3Y0.17%
Perf 5Y-85.84%
Perf 10Y-76.40%
Recom2.00
Target Price14.67
Prev Close10.03
Price10.48
Change %4.49%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Nov 10, 2026UpgradeRRaymond JamesUnderperform → Mkt Perform
Oct 07, 2026InitiatedBBarclaysEqual Weight$10-4.6%
Oct 21, 2025ResumedSStifelHold$9-14.1%
Aug 27, 2025InitiatedBBarclaysOverweight$1.50-85.7%
Jul 15, 2025InitiatedTTD CowenBuy$1.25-88.1%
Jun 02, 2025ResumedHH.C. WainwrightBuy$1.10-89.5%
Apr 10, 2025InitiatedMMizuhoOutperform$2-80.9%
Jul 19, 2023InitiatedJJefferiesUnderperform$0.50-95.2%
Aug 19, 2021InitiatedHH.C. WainwrightBuy$6-42.7%
Apr 01, 2021DowngradeSSVB LeerinkOutperform → Mkt Perform$3-71.4%

Peers

Mkt cap
TickerCompanyMkt cap
DXCMDexcom Inc29.89B
ABTAbbott Laboratories190.22B
BBNXBeta Bionics Inc950.88M
TNDMTandem Diabetes Care Inc1.35B
PODDInsulet Corp10.27B
MMEDMiniMed Group Inc5.15B
EMBCEmbecta Corp368.90M
TCMDTactile Systems Technology Inc596.83M
DRIODarioHealth Corp25.53M

Insider trading

4 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
ROEDER DOUGLAS ADirectorAug 19 '26Buy8.9813,953125,300171,191Aug 20 06:25 PM
ROEDER DOUGLAS ADirectorMay 12 '26Buy5.5622,686126,134144,635May 13 04:15 PM
ROEDER DOUGLAS ADirectorMar 13 '26Buy5.7317,500100,275119,731Mar 16 10:44 AM
Goodnow Timothy TPresident and CEOMar 13 '26Buy5.7917,22599,733651,243Mar 16 10:44 AM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
SCHASchwab U.S. Small-Cap ETFAUM: 22.25B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B
DWASInvesco Dorsey Wright SmallCap Momentum ETFAUM: 391.13M
IWCiShares Micro-Cap ETFAUM: 1.22B
XHEState Street SPDR S&P Health Care Equipment ETFAUM: 160.14M
ITOTiShares Core S&P Total U.S. Stock Market ETFAUM: 95.28B

News

latest 14 of 206
  • Senseonics' 140% Revenue Surge And Third Guidance Raise Outrun A Penny Miss, But Losses Keep Widening (Earnings Whispers) +14.09%
  • Senseonics: Q3 Earnings Snapshot (Associated Press)
  • Senseonics Holdings, Inc. Reports Third Quarter 2026 Financial Results (GlobeNewswire)
  • Senseonics Must Show Europe Recovery And Margin Discipline After Rally And Third Guidance Raise (Earnings Whispers) -5.57%
  • Senseonics Initiates First-in-Human Study of Freedom, Designed to be the World's First CGM System with No On-body Component (GlobeNewswire)
  • Loading…
  • Senseonics Holdings, Inc. to Participate in Upcoming Investor Conferences (GlobeNewswire) -7.15%
  • Senseonics Holdings, Inc. Schedules Third Quarter 2026 Earnings Release and Conference Call for November 9, 2026 at 4:30 P.M. Eastern Time (GlobeNewswire)
  • Flutter upgraded, AppFolio downgraded: Wall Street's top analyst calls (The Fly) -8.03%
  • Senseonics Announces Strategic Partnership with Beta Bionics to Integrate Eversense 365 with the iLet Bionic Pancreas (GlobeNewswire)
  • Senseonics To Participate in Upcoming Institutional Investor Conferences (GlobeNewswire)
  • Sensirion Holding AG (XSWX:SENS) (H1 2026) Earnings Call Highlights: Broad-Based Growth and ... (GuruFocus.com)
  • Senseonics Holdings Inc (SENS) (Q2 2026) Earnings Call Highlights: Revenue Soars 120% as ... (GuruFocus.com) +36.31%
  • Senseonics: Q2 Earnings Snapshot (Associated Press)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-09-0.500-0.516-0.50019.3416.208
2026Q22026-08-06-0.630-0.613-0.63514.5013.357
2026Q12026-05-07-0.710-0.686-0.70611.719.838
2025Q42026-03-02-0.460-0.435-0.50514.3014.247
2025Q32025-11-05-0.430-0.374-0.4348.107.997
2025Q22025-08-06-0.400-0.400-0.3576.656.026
2025Q12025-05-08-0.400-0.450-0.3976.265.554
2024Q42025-03-03-0.400-0.642-0.5208.307.955
2024Q32024-11-07-0.800-0.680-0.7724.264.085
2024Q22024-08-08-0.600-0.600-0.6584.904.934
2024Q12024-05-13-0.600-0.600-0.6145.054.615
2023Q42024-02-29-0.600-0.792-0.6488.007.505
2023Q32023-11-09-0.800-0.702-0.8146.105.475
2023Q22023-08-10-0.800-0.760-0.7204.134.585
2023Q12023-05-090.000-0.700-0.0364.143.374
2022Q42023-03-150.400-0.826-0.2655.605.435

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY-12.200-12.796-12.24321.3020.45
2020FY-15.400-8.624-15.3724.954.18
2021FY-14.400-18.700-14.32413.6813.65
2022FY-2.778-3.268-2.17216.3916.23
2023FY-2.200-2.482-2.12722.4021.88
2024FY-2.400-2.771-2.49722.4722.13
2025FY-1.660-1.463-1.66035.3035.20
2026FY--2.215--67.63
2027FY--1.836--106.72
2028FY--1.454--148.87
2029FY--0.773--212.05
2030FY--0.163--284.71

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-1076023.4522.8023.90
2026Q4S2026-11-0970021.8519.7023.80
2026Q4S2026-10-2170021.8519.7023.80
2026Q4S2026-10-1271221.8519.7023.80
2026Q4S2026-10-0971221.8519.7023.80
2026Q4S2026-09-2771221.8419.7023.80
2026Q4S2026-08-0771321.8419.7023.80
2026Q4S2026-07-2570121.9719.8023.80
2026Q4S2026-07-2271121.9719.8023.80
2026Q4S2026-07-1472321.9619.8023.80
2026Q4S2026-06-0573222.0319.8023.80
2026Q4S2026-05-1872321.9719.8023.80
2026Q4S2026-05-1772421.9719.8023.80
2026Q4S2026-05-1373421.9719.8023.80

Estimate history

EPS, annual-10.192-11.938-12.243-15.372-14.324-2.172-2.127-2.497-1.656-2.3419
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.772-0.52-0.397-0.357-0.434-0.505-0.706-0.635-0.497
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual6.37318.91321.3014.94913.67516.38922.3922.47235.25760.01
Period201720182019202020212022202320242025TTM
Sales, quarterly4.2638.2976.2576.6498.09514.25611.71114.48319.561
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual6.8448.84610.17313.27922.36423.98226.51829.76841.26654.776
Period201720182019202020212022202320242025MRQ
Shares, quarterly27.28129.76832.71140.72940.81341.26641.79552.86554.776
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue60.0135.2622.4722.3916.3913.684.9521.3018.91
Cost of Goods Sold Incl. D&A24.7719.4921.9419.3013.6614.4922.3240.7527.33
Gross Profit35.2415.760.533.092.73-0.81-17.37-19.45-8.42
Selling, General and Administrative Excl. Other155.8584.1075.3878.6971.3556.3761.76111.2179.16
Research and Development40.7431.5941.1448.7539.7227.2220.4138.4331.86
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-120.61-68.34-74.84-75.60-68.63-57.18-79.13-130.66-87.58
Interest Expense5.814.958.4411.1118.7016.7216.1715.148.28
Unusual Expense0.000.00-0.10-20.76-227.73228.6479.73-28.83-0.21
Net Income Before Taxes-122.54-69.11-78.62-60.39142.12-302.47-175.17-115.55-93.97
Income Taxes0.000.000.000.000.000.000.000.000.00
Consolidated Net Income-122.54-69.11-78.62-60.39142.12-302.47-175.17-115.55-93.97
Net Income From Continuing Operations-122.54-69.11-78.62-60.39142.12-302.47-175.17-115.55-93.97
Net Income-122.54-69.11-78.62-60.39142.12-302.47-175.17-115.55-93.97
EPS (Recurring)-1.86-1.66-2.50-2.64-7.33-6.74-10.47-14.38-11.96
EPS (Basic, Before Extraordinaries)-2.34-1.66-2.50-2.136.07-14.32-15.37-12.24-11.94
EPS (Diluted)-2.34-1.66-2.50-2.13-2.17-14.32-15.37-12.24-11.94
EBITDA-118.66-66.83-73.37-74.33-67.64-55.94-77.99-129.66-87.31
Non-Operating Income (Expense)3.894.174.565.561.720.07-0.141.421.68
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense12.0310.159.228.678.629.037.258.056.38
Price To Sales Ratio11.146.5314.6714.4638.8582.4640.158.1221.56
Gross Margin58.7244.712.3713.8116.63-5.93-350.90-91.30-44.50
Operating Margin-200.99-193.83-333.05-337.66-418.74-418.15-1,598.91-613.41-463.06
Net Margin-204.19-196.03-349.84-269.73867.16-2,211.88-3,539.46-542.46-496.86
Shares Outstanding54.7841.2729.7726.5223.9822.3613.2810.178.85
Market Capitalization530.33530.33311.61301.11492.561,194.24231.53186.36458.22

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue19.5614.4811.7114.268.106.656.268.30
Cost of Goods Sold Incl. D&A7.495.924.776.594.633.534.754.35
Gross Profit12.078.566.947.673.473.121.503.95
Selling, General and Administrative Excl. Other43.9244.5538.7928.5923.0717.4414.9918.22
Research and Development11.6711.648.618.827.767.717.309.36
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-31.86-35.99-31.85-20.93-19.60-14.32-13.49-14.27
Interest Expense1.811.601.191.211.171.151.432.17
Unusual Expense0.000.000.000.000.000.000.000.00
Net Income Before Taxes-32.68-36.70-32.33-20.82-19.53-14.50-14.26-15.48
Income Taxes0.000.000.000.000.000.000.000.00
Consolidated Net Income-32.68-36.70-32.33-20.82-19.53-14.50-14.26-15.48
Net Income From Continuing Operations-32.68-36.70-32.33-20.82-19.53-14.50-14.26-15.48
Net Income-32.68-36.70-32.33-20.82-19.53-14.50-14.26-15.48
EPS (Recurring)-0.50-0.63-0.71-0.50-0.43-0.36-0.40-0.52
EPS (Basic, Before Extraordinaries)-0.50-0.63-0.71-0.50-0.43-0.36-0.40-0.52
EPS (Diluted)-0.50-0.63-0.71-0.50-0.43-0.36-0.40-0.52
EBITDA-31.38-35.44-31.30-20.54-19.23-13.95-13.10-13.51
Non-Operating Income (Expense)0.990.880.701.311.240.970.660.97
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense3.563.572.282.622.792.891.842.06
Price To Sales Ratio11.146.777.506.4613.3715.2219.9213.87
Gross Margin61.7059.1059.2653.7942.8446.9424.0547.62
Operating Margin-162.85-248.48-271.93-146.78-242.14-215.42-215.57-172.00
Net Margin-167.05-253.44-276.09-146.06-241.26-218.09-227.89-186.53
Shares Outstanding54.7852.8641.8041.2740.8140.7332.7129.77
Market Capitalization530.33296.51278.19225.54355.72388.06429.23311.61

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments94.3474.91109.46144.01129.9118.2095.94136.7936.45
Short Term Receivables12.438.084.802.792.422.9910.497.343.39
Inventories6.704.428.787.316.325.2816.9310.232.99
Other Current Assets4.054.036.997.095.783.774.413.752.09
Total Current Assets117.5391.44130.03161.20144.4130.25127.76158.1144.91
Net Property, Plant & Equipment7.868.916.364.142.133.694.821.750.85
Total Investments and Advances0.000.000.0012.2552.121.890.000.000.00
Intangible Assets0.80--------
Other Assets0.080.091.830.080.270.100.220.120.18
Total Assets126.27100.44138.22177.67198.9335.92132.80159.9745.94
Short Term Debt Incl. Current Port. of LT Debt0.5020.570.3716.303.834.00104.4810.0010.00
Accounts Payable4.063.214.570.421.201.764.294.417.71
Other Current Liabilities19.7915.0812.3214.7513.3610.8817.9414.485.43
Total Current Liabilities24.3538.8517.2631.4718.3916.64126.7128.8923.14
Long Term Debt40.8840.4947.4159.0760.3858.7014.7440.8914.41
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Other Liabilities0.000.000.1052.05305.69101.850.0018.941.12
Total Liabilities65.2279.3464.77142.59384.46177.19141.4588.7138.68
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.0037.6637.6637.660.002.810.000.000.00
Common Equity61.05-16.5535.80-2.58-185.53-144.08-8.6571.267.27
Total Shareholders Equity61.0521.1073.4535.08-185.53-141.27-8.6571.267.27
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity61.0521.1073.4535.08-185.53-141.27-8.6571.267.27
Total Liabilities & Stockholders Equity126.27100.44138.22177.67198.9335.92132.80159.9745.94
Book Value Per Share1.48-0.561.35-0.11-8.30-10.85-0.858.061.06
Tangible Book Value Per Share1.46-0.561.35-0.11-8.30-10.85-0.858.061.06
Full-Time Employees130117132121898219119294
Price to Book Ratio7.08-18.825.78-32.70-6.44-1.61-21.556.4316.34
Return on Assets-60.97-65.88-38.2475.47-257.59-207.64-78.93-91.27-173.28
Return on Equity-168.27-166.29-111.29----369.10-239.33-4,945.69
Return on Invested Capital-67.81-127.65-49.97150.95---1,896.42-83.79-272.59
Quick Ratio4.552.247.034.897.511.500.875.121.81
Current Ratio4.832.357.535.127.851.821.015.471.94

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-122.54-69.11-78.62-60.39142.12-302.47-175.17-115.55-93.97
Depreciation1.951.511.481.280.981.241.141.000.27
Other Funds (Non Cash)14.7111.3415.81-7.08-206.94246.6692.82-8.049.61
Funds from Operations-105.87-56.26-61.33-66.20-63.84-54.57-81.21-122.59-84.09
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-7.19-3.280.86-3.97-2.47-1.5013.79-13.45-6.68
Cash from Operating Activities-113.06-59.54-60.47-70.16-66.31-56.08-67.42-136.05-90.77
Capital Expenditures-2.24-1.12-2.24-0.35-0.31-0.21-0.18-1.04-0.99
Net Assets From Acquisitions0.000.000.000.000.000.000.000.00-
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.00-
Purchase or Sale of Investments-0.98-52.3135.0890.0627.19-148.540.000.0020.41
Purchase of Investments-101.08-100.69-58.02-68.54-104.71-154.510.000.00-7.93
Sale Or Maturity of Investments100.1048.3993.09158.60131.905.970.000.0028.35
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-3.22-53.4232.8489.7126.88-148.75-0.18-1.0419.43
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock111.63100.7318.5422.1547.26228.210.5527.59151.30
Repurchase of Common Pref Stock0.000.000.000.000.000.00-0.030.000.00
Sale of Common Pref Stock111.63100.7318.5422.1547.26228.210.5827.59151.30
Proceedsfrom Stock Options71.45100.593.817.3846.17223.150.0026.76149.04
Issuance or Reduction of Debt, Net19.80-20.409.950.89-2.93-2.84-10.6868.6540.69
Change in Long Term Debt19.80-20.409.950.89-2.93-2.84-10.6868.6540.69
Issuance of Long Term Debt19.800.009.9524.090.000.0055.37120.6552.95
Reduction of Long Term Debt0.00-20.400.00-23.20-2.93-2.84-66.05-52.00-12.27
Net Financing Active Other Cash Flow-1.85-1.74-1.66-2.67-2.57-5.290.000.000.00
Other Financing Activities Uses-1.85-1.74-1.66-2.67-2.57-5.290.000.000.00
Cash from Financing Activities129.5978.6026.8320.3741.76220.08-10.1396.24191.99
Net Change in Cash13.30-34.36-0.8039.922.3315.26-77.73-40.85120.64
Free Cash Flow-115.31-60.66-62.70-70.51-66.62-56.29-67.60-137.09-91.76
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments126.62142.9764.6494.34111.27126.73
Short Term Receivables13.8210.7615.0512.439.377.23
Inventories8.448.468.316.706.324.71
Other Current Assets4.034.264.294.054.312.92
Total Current Assets152.90166.4692.28117.53131.28141.59
Net Property, Plant & Equipment8.579.369.407.868.578.61
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets0.800.800.800.80--
Other Assets0.240.220.380.080.080.08
Total Assets162.51176.84102.86126.27139.92150.27
Short Term Debt Incl. Current Port. of LT Debt3.440.970.940.500.480.46
Accounts Payable2.504.823.194.065.932.27
Other Current Liabilities19.8718.8822.1919.7914.6612.04
Total Current Liabilities25.8124.6826.3224.3521.0714.78
Long Term Debt59.0761.8442.2040.8840.6940.78
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities0.000.000.000.000.000.00
Total Liabilities84.8986.5268.5265.2261.7655.55
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity77.6290.3134.3461.0578.1794.72
Total Shareholders Equity77.6290.3134.3461.0578.1794.72
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity77.6290.3134.3461.0578.1794.72
Total Liabilities & Stockholders Equity162.51176.84102.86126.27139.92150.27
Book Value Per Share1.421.710.821.481.922.33
Tangible Book Value Per Share1.401.690.801.461.922.33
Full-Time Employees---130--
Price to Book Ratio7.086.914.502.884.554.10
Return on Assets-81.04-66.88-91.74-60.97-53.98-52.10
Return on Equity-157.32-118.24-250.78-168.27-129.29-102.61
Return on Invested Capital-23.91-24.12-42.25-20.43-16.43-10.70
Quick Ratio5.606.403.194.555.939.26
Current Ratio5.926.743.514.836.239.58

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-32.68-36.70-32.33-20.82-19.53-14.50
Depreciation0.480.550.550.380.380.37
Other Funds (Non Cash)4.654.322.483.262.403.10
Funds from Operations-27.55-31.84-29.31-17.18-16.75-11.03
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-5.391.70-2.72-0.780.531.76
Cash from Operating Activities-32.94-30.14-32.02-17.96-16.23-9.27
Capital Expenditures-1.52-0.22-0.11-0.39-0.16-0.12
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments19.75-62.9819.2223.0419.05-69.51
Purchase of Investments-2.65-94.39-4.040.00-6.29-69.51
Sale Or Maturity of Investments22.4031.4023.2623.0425.350.00
Other Uses1.28-0.17-1.110.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities19.51-63.3818.0022.6418.89-69.63
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock16.4389.993.561.660.2872.28
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock16.4389.993.561.660.2872.28
Proceedsfrom Stock Options16.3050.003.491.660.2072.27
Issuance or Reduction of Debt, Net0.0019.800.000.000.000.00
Change in Long Term Debt0.0019.800.000.000.000.00
Issuance of Long Term Debt0.0019.800.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.00-1.13-0.15-0.560.00-1.17
Other Financing Activities Uses0.00-1.13-0.15-0.560.00-1.17
Cash from Financing Activities16.43108.663.411.100.2871.11
Net Change in Cash3.0115.14-10.625.782.94-7.79
Free Cash Flow-34.46-30.36-32.14-18.36-16.39-9.39

Revenue breakdown

Industrial Instruments For Measurement, Display, and Control2024: 22.47M 2025: 35.26M
Non-US2024: 7.19M 2025: 7.35M
United States2024: 15.28M 2025: 27.91M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3010.18%4.7M46.6M714.06K
2026-10-1510.46%4.9M46.6M681.12K
2026-09-3011.53%5.4M46.6M683.25K
2026-09-1510.85%5.1M46.6M732.26K
2026-08-3111.19%5.2M46.6M725.83K
2026-08-1412.58%5.8M46.5M697.74K
2026-07-3113.42%6.2M45.9M910.47K
2026-07-1513.97%6.4M45.9M897.42K
2026-06-3012.60%5.8M45.9M833.08K
2026-06-1510.48%4.8M45.9M706.46K
2026-05-2910.03%4.6M45.9M728.46K
2026-05-1511.58%5.1M44.3M702.35K
2026-04-3012.95%5.2M40.5M442.15K
2026-04-1511.99%4.8M40.0M473.34K
2026-03-3112.11%4.5M37.3M490.67K
2026-03-1313.01%4.8M37.3M513.18K
2026-02-2712.12%4.5M37.3M445.62K
2026-02-1313.10%4.8M36.5M463.81K
2026-01-3011.71%4.3M36.5M443.15K
2026-01-1511.12%4.1M36.5M474.97K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.506.609.209.7014.0864.000.000.987-0.0160.001
call5.004.006.300.006.2680.000.000.974-0.0150.001
call7.501.303.504.603.08160.000.000.838-0.0590.004
call10.000.450.900.691.02783624.000.637-0.0350.006
call12.500.000.100.100.98517139.000.132-0.0190.003
call15.000.000.400.051.5992536.000.091-0.0240.003
call17.500.000.200.152.0864.000.000.075-0.0270.002
put2.500.000.750.004.9480.000.00-0.013-0.0150.001
put5.000.000.050.012.4813150.00-0.028-0.0130.001
put7.500.000.750.042.6642330.00-0.160-0.0590.004
put10.000.350.450.351.0111,08043.00-0.363-0.0340.006
put12.501.952.452.241.56520.003.00-0.867-0.0180.004
put15.003.306.700.005.2350.000.00-0.909-0.0220.003
put17.505.809.200.005.9030.000.00-0.925-0.0250.002

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-0910-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-098-KCurrent report2026-11-09SEC
2026-10-27SCHEDULE 13G/ASEC
2026-10-054Statement of changes in beneficial ownership of securities2026-10-01SEC
2026-10-054Statement of changes in beneficial ownership of securities2026-10-01SEC
2026-10-054Statement of changes in beneficial ownership of securities2026-10-01SEC
2026-08-204Statement of changes in beneficial ownership of securities2026-08-19SEC
2026-08-14SCHEDULE 13GSEC
2026-08-0610-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-068-KCurrent report2026-08-06SEC
2026-07-30SCHEDULE 13GSEC
2026-07-024Statement of changes in beneficial ownership of securities2026-07-01SEC
2026-07-024Statement of changes in beneficial ownership of securities2026-07-01SEC
2026-07-024Statement of changes in beneficial ownership of securities2026-07-01SEC
2026-07-024Statement of changes in beneficial ownership of securities2026-07-01SEC
2026-06-174Statement of changes in beneficial ownership of securities2026-06-15SEC
2026-06-174Statement of changes in beneficial ownership of securities2026-06-15SEC
2026-06-174Statement of changes in beneficial ownership of securities2026-06-15SEC
2026-06-174Statement of changes in beneficial ownership of securities2026-06-15SEC
2026-06-174Statement of changes in beneficial ownership of securities2026-06-15SEC
2026-06-174Statement of changes in beneficial ownership of securities2026-06-15SEC
2026-06-088-KCurrent report2026-06-01SEC
2026-06-01SDSpecialized Disclosure ReportSEC
2026-05-214Statement of changes in beneficial ownership of securities2026-05-19SEC
2026-05-214Statement of changes in beneficial ownership of securities2026-05-20SEC
2026-05-214Statement of changes in beneficial ownership of securities2026-05-19SEC
2026-05-214Statement of changes in beneficial ownership of securities2026-05-20SEC
2026-05-214Statement of changes in beneficial ownership of securities2026-05-19SEC
2026-05-214Statement of changes in beneficial ownership of securities2026-05-19SEC
2026-05-214Statement of changes in beneficial ownership of securities2026-05-20SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-08125.30K100
2026-070000
2026-060000
2026-05126.13K100
2026-040000
2026-03200.01K200
2026-020000
2026-010000
2025-120000
2025-11184.79K300

Institutional holders

Manager% owned
Sessa Capital IM, L.P.8.50%
BlackRock, Inc.5.35%
VANGUARD CAPITAL MANAGEMENT LLC3.41%
Avidity Partners Management LP3.06%
Sio Capital Management, LLC3.05%
GEODE CAPITAL MANAGEMENT, LLC2.13%
UBS Group AG1.85%
MASTERS CAPITAL MANAGEMENT LLC1.34%
STATE STREET CORP0.98%
MARSHALL WACE, LLP0.78%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND2.25%
iShares Russell 2000 ETF1.86%
VANGUARD EXTENDED MARKET INDEX FUND1.07%
Fidelity Small Cap Index Fund0.82%
iShares Russell 2000 Growth ETF0.71%
Fidelity Extended Market Index Fund0.46%
VANGUARD RUSSELL 2000 INDEX FUND0.43%
Schwab U.S. Small-Cap ETF0.43%
iShares Micro-Cap ETF0.25%
Schwab Small-Cap Index Fund0.18%

OakChart. SENS. Cached 15 minutes.